Are Investors Undervaluing Molina Healthcare (MOH) Right Now?

05.05.25 15:40 Uhr

Werte in diesem Artikel
Indizes

5.842,0 PKT -2,6 PKT -0,04%

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.Considering these trends, value investing is clearly one of the most preferred ways to find strong stocks in any type of market. Value investors use fundamental analysis and traditional valuation metrics to find stocks that they believe are being undervalued by the market at large.On top of the Zacks Rank, investors can also look at our innovative Style Scores system to find stocks with specific traits. For example, value investors will want to focus on the "Value" category. Stocks with high Zacks Ranks and "A" grades for Value will be some of the highest-quality value stocks on the market today.One company value investors might notice is Molina Healthcare (MOH). MOH is currently sporting a Zacks Rank of #2 (Buy), as well as an A grade for Value. The stock is trading with P/E ratio of 12.27 right now. For comparison, its industry sports an average P/E of 13.20. Over the past 52 weeks, MOH's Forward P/E has been as high as 14.33 and as low as 10.15, with a median of 12.40.Investors will also notice that MOH has a PEG ratio of 1.01. This figure is similar to the commonly-used P/E ratio, with the PEG ratio also factoring in a company's expected earnings growth rate. MOH's industry currently sports an average PEG of 1.17. Over the past 52 weeks, MOH's PEG has been as high as 1.24 and as low as 0.81, with a median of 1.Finally, we should also recognize that MOH has a P/CF ratio of 12.57. This data point considers a firm's operating cash flow and is frequently used to find companies that are undervalued when considering their solid cash outlook. MOH's current P/CF looks attractive when compared to its industry's average P/CF of 15.22. Within the past 12 months, MOH's P/CF has been as high as 16.95 and as low as 11.03, with a median of 13.72.These are just a handful of the figures considered in Molina Healthcare's great Value grade. Still, they help show that the stock is likely being undervalued at the moment. Add this to the strength of its earnings outlook, and we can clearly see that MOH is an impressive value stock right now.Only $1 to See All Zacks' Buys and SellsWe're not kidding.Several years ago, we shocked our members by offering them 30-day access to all our picks for the total sum of only $1. No obligation to spend another cent.Thousands have taken advantage of this opportunity. Thousands did not - they thought there must be a catch. Yes, we do have a reason. We want you to get acquainted with our portfolio services like Surprise Trader, Stocks Under $10, Technology Innovators,and more, that closed 256 positions with double- and triple-digit gains in 2024 alone.See Stocks Now >>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Molina Healthcare, Inc (MOH): Free Stock Analysis ReportThis article originally published on Zacks Investment Research (zacks.com).Zacks Investment ResearchWeiter zum vollständigen Artikel bei Zacks

Quelle: Zacks

Nachrichten zu Molina Healthcare

Wer­bung

Analysen zu Molina Healthcare

DatumRatingAnalyst
03.06.2019Molina Healthcare OutperformBMO Capital Markets
20.10.2017Molina Healthcare Market PerformBMO Capital Markets
31.05.2017Molina Healthcare SellStifel, Nicolaus & Co., Inc.
05.04.2017Molina Healthcare HoldDeutsche Bank AG
21.03.2017Molina Healthcare Equal WeightBarclays Capital
DatumRatingAnalyst
03.06.2019Molina Healthcare OutperformBMO Capital Markets
20.10.2017Molina Healthcare Market PerformBMO Capital Markets
16.02.2017Molina Healthcare HoldStifel, Nicolaus & Co., Inc.
29.04.2016Molina Healthcare BuyStifel, Nicolaus & Co., Inc.
31.07.2015Molina Healthcare BuyStifel, Nicolaus & Co., Inc.
DatumRatingAnalyst
05.04.2017Molina Healthcare HoldDeutsche Bank AG
21.03.2017Molina Healthcare Equal WeightBarclays Capital
02.11.2015Molina Healthcare Equal WeightBarclays Capital
02.06.2015Molina Healthcare HoldDeutsche Bank AG
13.02.2015Molina Healthcare Equal WeightBarclays Capital
DatumRatingAnalyst
31.05.2017Molina Healthcare SellStifel, Nicolaus & Co., Inc.

Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für Molina Healthcare nach folgenden Kriterien zu filtern.

Alle: Alle Empfehlungen

Buy: Kaufempfehlungen wie z.B. "kaufen" oder "buy"
Hold: Halten-Empfehlungen wie z.B. "halten" oder "neutral"
Sell: Verkaufsempfehlungn wie z.B. "verkaufen" oder "reduce"
mehr Analysen